<TAB>Digene Corp. has settled a licensing dispute with Georgetown University that threatened to snatch away a key part of its cervical cancer screening tests, the company said ...
Digene Corp., a Gaithersburg-based maker of diagnostic tests, announced yesterday the termination of its merger with Cytyc Corp. The decision was widely expected after the Federal Trade Commission ...
Shares of Digene Inc. of Gaithersburg plummeted 33 percent yesterday after Cytyc Corp., the Massachusetts company preparing to acquire Digene, lowered revenue forecasts as its major customers reduced ...
Digene Gel is an over-the-counter antacid medication used to relieve symptoms associated with acidity, heartburn, and indigestion. This type of antacid is taken orally and works by neutralizing excess ...
Facing increased competition for its main product – the HPV Test – and questions about its plans for growth, Gaithersburg’s Digene Corp. agreed yesterday to be acquired by a foreign company in a $1.6 ...
The name of Joe Simons, director of the Federal Trade Commission's Bureau of Competition, was misspelled in a June 25 Business article. (Published 6/26/02) The Federal Trade Commission voted ...
Abbott India has recently recalled its Digene Gel product from the market after the Drug Controller General of India (DCGI) issued an advisory against its sale. Drug Controller General of India (DCGI) ...
Shares of Digene, a maker of DNA and RNA tests, sizzled on Monday after it announced that Netherlands-based Qiagen would purchase the company in a $1.6 billion deal. Digene is best known for a test to ...
QIAGEN N.V. has announced the successful completion of its acquisition of Digene Corporation. QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a ...
Evan Jones, the longtime CEO of Digene, one of the Washington area's few profitable biotech companies, dropped a bombshell this week. He shocked the local biotech community, and the diagnostics ...
The Daily Record is a digital-first daily news media company focused on law, government, business, recognition events, Power Lists, special products, public notices and more.
Deal consolidates firms’ technology in molecular diagnostics. Qiagen and Digene entered into a definitive agreement to combine the two companies to create market and technology leadership in molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results